Oxidized lipoproteins found in patients with NIDDM stimulate radical- induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells

Diabetologia

Volumn 40, Issue 6, 1997, Pages 662-670

  Takahara, N ^a   Kashiwagi, A ^a   Nishio, Y ^a   Harada, N ^a   Kojima, H ^a   Maegawa, H ^a   Hidaka, H ^a   Kikkawa, R ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Antioxidants; Atherosclerosis; Endothelial cells; Free radical; Oxidized lipoprotein

Indexed keywords

MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; HUMAN; HUMAN CELL; LIPID OXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK FACTOR;

ANTIOXIDANTS; CELLS, CULTURED; CHEMOKINE CCL2; DEFEROXAMINE; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PROBUCOL; REFERENCE VALUES; REGRESSION ANALYSIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UMBILICAL VEINS; VITAMIN E;

EID: 0030806968     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050731     Document Type: Article

References (50)

1. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease: the Framingham Study. JAMA 241: 2035-2038
2. Baynes JW (1991) The role of oxidative stress in the development of complications in diabetes. Diabetes 40: 405-412
3. Chisolm GM, Irwin KC, Penn MS (1992) Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 41[Suppl 2]:61-66
4. Hunt JV, Smith CCT, Wolf SP (1990) Autooxidative glycation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39: 1420-1424
5. Lopes-Virella MF, Virella G (1996) Cytokines, modified lipoproteins, and arteriosclerosis in diabetes. Diabetes 45[Suppl 3]:S40-S44
6. Giugliano D, Paolisso G, Ceriello A (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267
7. Sobenin IA, Tertov VV, Koschinsky T et al. (1993) Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis. 100: 41-54
8. Bagdade JD, Buchana WE, Kuusi T, Taskinen MR (1990) Persistent abnormalities in lipoprotein composition in non insulin-dependent diabetes after intensive insulin therapy. Arteriosclerosis 10: 232-239
9. Palinski W, Rosenfeld ME, Yla-Herttuala S et al. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86: 1372-1376
10. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90: 6434-6438
11. Tsai EC, Hirsch IB, Brunzell JD, Chait A (1994) Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43: 1010-1014
12. Haffner SM, Agil A, Mykkanen L, Stern, MP, Jialal I (1995) Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 18: 646-653
13. Sparow CP, Parthasarathy S, Steinberg D (1989) A macrophage receptor that recognizes oxidized LDL but not acetylated LDL. J Biol Chem 264: 2599-2604
14. Berliner JA, Territo MC, Sevanian A et al. (1990) Minimally modified low density lipoproteins stimulates monocyte endothelial interactions. J Clin Invest 85: 1260-1266
15. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD (1990) Impairment of endothelial-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature (London) 344: 160-162
16. Rajavashisth TB, Andalbi A, Territo MC et al. (1990) Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature (London) 344: 254-257
17. Cushing SD, Berliner JA, Valente AJ et al. (1990) Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87: 5134-5138
18. Lyons TJ, Klein RL, Baynes JW, Stevenson HC, Lopes-Virella MF (1987) Stimulation of CE synthesis in human monocyte-derived macrophages by LDL from type 1 diabetic patients: the influence on non-enzymatic glycosylation of LDL. Diabetologia 30: 916-923
19. Ylä-Herttuala S, Lipton BA, Rosenfeld ME et al. (1991) Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88: 5252-5256
20. Nelken NA, Coughin SR, Gordon D, Wilcox JN (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88: 1121-1127
21. Collins T (1993) Endothelial nuclear factor-κB and initiation of the atherosclerotic lesion. Lab Invest 68: 499-508
22. Sen CK, Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720
23. World Health Organization (1985) Diabetes mellitus: report of a WHO study group. World Health Organization Technical Report Series 727, Geneva
24. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353
25. Ikebuchi M, Kashiwagi A, Asahina T et al. (1993) Effect of medium pH on glutathione redox cycle in cultured human umbilical vein endothelial cells. Metabolism 42: 1121-1126
26. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Anal Biochem 162: 156-159
27. Takahara N, Kashiwagi A, Maegawa H, Shigeta Y (1996) Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism 45: 559-564
28. Bligh EG, Dyer J (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917
29. Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234: 466-468
30. Lowry OH, Rosebrough MJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin Phenol reagent. J Biol Chem 193: 265-275
31. Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Res Com 6: 67-75
32. Compton JL, Bellard M, Chambon P (1976) Biochemical evidence of variability in the DNA repeat length in the chromatin of higher eukaryotes. Proc Natl Acad Sci USA 73: 4382-4386
33. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, Fogelman AM (1991) Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 87: 2253-2257
34. Heery JM, Kozak M, Stafforini DM et al. (1995) Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest 96: 2322-2330
35. Stiko A, Regnstrom J, Shah PK, Cercek B, Nilsson J (1995) Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis. Arterioscler Thromb Vasc Biol 16: 194-200
36. Nakano T, Raines EW, Abraham JA, Klagsbrun M, Ross R (1994) Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA 91: 1069-1073
37. Kume N, Gimbrone MA (1994) Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93: 907-911
38. Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamste A (1992) Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339: 1183-1186
39. Satriano JA, Shuldiner M, Kazuhiko H, Xing Y, Shan Z, Schlondorff D (1993) Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, M-CSF, in response to tumor necrosis factor-α and immunoglobulin G. J Clin Invest 92: 1564-1571
40. Khan BV, Parthasarathy SS, Alexander RW, Medford RM (1995) Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95: 1262-1270
41. Coffey MD, Cole RA, Colles SM, Chisolm GM (1995) In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid and peroxyl radicals. J Clin Invest 96: 1866-1873
42. Sasahara M, Raines EW, Chait A et al. (1995) Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. J Clin Invest 94: 155-164
43. Keaney JF, Xu A, Cunningham D, Jackson T, Frei B, Vita JA (1995) Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 95: 2520-2529
44. Faruqi R, Motte C, Dicorleto PE (1994) α-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 94: 592-600
45. Navab M, Imes SS, Hama SY et al. (1991) Monocyte transmigration induced by modification of low density lipoprotein in culture of human aortic wall cells is due to induction of monocyte chemotactic protein 1 and is abolished by high density lipoprotein. J Clin Invest 88: 2039-2046
46. Brand K, Page S, Rogler G et al. (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 97: 1715-1722
47. Rajavashisth TB, Yamada H, Mishra NK (1995) Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-kappa B. Arterioscler Thromb Vasc Biol 15: 1591-1598
48. Liao F, Andalibi A, DeBeer FC, Fogelman AM, Lusis AJ (1993) Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91: 2572-2579
49. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ (1994) Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest 95: 877-884
50. Watson A, Navab M, Hama S et al. (1995) Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 95: 774-782